Skip to main navigation

Top

Skip to main content

About Us

About Us
Rare Diseases

Rare Defined Diseases
Pipeline

Pipeline
Our Medicine

Our Medicine
Patients & Partners

Patients & Partners
Investors

Investors
Inside Agios

Inside Agios

Press Releases

Investors Overview
News & Events
Stock Information
Corporate Governance
Financials
IR Resources

Year

Nov 20, 2023

Agios Announces Clinical Proof-of-Concept in Phase 2a Trial of AG-946 for the Treatment of Anemia in Lower-Risk Myelodysplastic Syndromes

Read More

PDF Version

Nov 02, 2023

Agios Pharmaceuticals to Present Broad Set of Clinical and Translational Data in Rare Blood Disorders at 65th ASH Annual Meeting and Exposition

Read More

PDF Version

Nov 02, 2023

Agios Reports Business Highlights and Third Quarter 2023 Financial Results

Read More

PDF Version

Oct 19, 2023

Agios to Webcast Conference Call of Third Quarter 2023 Financial Results on Nov. 2, 2023

Read More

PDF Version

Aug 29, 2023

Agios to Present at the Morgan Stanley Global Healthcare Conference on September 12, 2023

Read More

PDF Version

Aug 03, 2023

Agios Reports Business Highlights and Second Quarter 2023 Financial Results

Read More

PDF Version

Aug 03, 2023

Agios Announces Exclusive Worldwide License Agreement with Alnylam for Novel siRNA for the Potential Treatment of Polycythemia Vera

Read More

PDF Version

Jul 13, 2023

Agios to Webcast Conference Call of Second Quarter 2023 Financial Results on Aug. 3, 2023

Read More

PDF Version

Jun 26, 2023

Agios Announces Positive Results from Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease with Both Mitapivat Dose Arms Achieving Statistically Significant Hemoglobin Response

Read More

PDF Version

Jun 05, 2023

Agios to Present at the Goldman Sachs Global Healthcare Conference on June 15, 2023

Read More

PDF Version

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Displaying 1 - 10 of 23

Latest Earnings Call View Replay
Latest Form 10-K View PDF
Email Alerts Sign Up
Corporate Fact Sheet View PDF
Corporate Responsibility View PDF

Connect with us on LinkedIn or follow us on Twitter as we push forward into changing the landscape for people with rare diseases.

Connect on LinkedIn

Follow us our Twitter

Contact
About Us
Partner Opportunities
Careers

Agios Pharmaceuticals, Inc. © 2023

All right reserved.

Cookies Preferences
Copyright Info
Compliance
Sitemap
Privacy Notice
Terms of Use